SUBSCRIBE
SUBSCRIBE
News   Business

Crucell N.V. Announces European Protein Distribution Deal with Talecris Biotherapeutics

April 3, 2007 | 
1 min read
LEIDEN, NETHERLANDS -- (MARKET WIRE) -- April 03, 2007 -- Dutch biotechnology company Crucell N.V. (Euronext, NASDAQ: CRXL, Swiss Exchange: CRX) today announced a long-term distribution deal with North Carolina-headquartered Talecris Biotherapeutics, GmBH.
Alliances Europe
MORE ON THIS TOPIC
Contemporary art collage of woman sitting in the lotus position, cloud, pillows against the background of the night sky. Concept of healthy lifestyle and sport. Good and relaxing sleep. Copy space.
Mergers & acquisitions
Another Bidding War Breaks as Lundbeck Bids for Sleep Biotech Avadel
November 14, 2025
 · 
1 min read
 · 
Annalee Armstrong
Investment mistakes, taxes, expenses, and unknown costs drain money, concept of Businessman carries a money bag with a big hole, banknotes falling out
Mergers & acquisitions
Merck Again Brings Out Big Bucks, Buys Cidara in $9.2B Antiviral Push
November 14, 2025
 · 
2 min read
 · 
Tristan Manalac
Different business strategies. Various solutions. Splitting opinions. Choosing way. Movement options. Separation of directions. Dilemma concept. Two diverging paths of arrows. 3d render
Vaccines
Pfizer Reportedly Planning To Divest BioNTech Stake
November 14, 2025
 · 
2 min read
 · 
Tristan Manalac
Shanghai.China-Feb.25th 2022: Pfizer company sign on office building. Pharmaceutical and biotechnology corporation
Mergers & acquisitions
Pfizer Closes Metsera Deal, Officially Ending Bidding War Drama
November 13, 2025
 · 
1 min read
 · 
Annalee Armstrong